Japan Tissue Engineering Co., Ltd. (7774.T) Comparison with companies in other sectors?

Japan Tissue Engineering Co., Ltd. has a share price of 40.61M. You can analyze Japan Tissue Engineering Co., Ltd. (7774.T) competitors across different market sectors through stock heatmaps.

What are 7774.T's NET and operating margins?

Japan Tissue Engineering Co., Ltd. (7774.T) operating margin is around -0.07, and net profit margin is approximately -0.10 as of the latest reports.

In what way does 7774.T's earnings per share (EPS) trend reflect its financial momentum?

Japan Tissue Engineering Co., Ltd. (7774.T) EPS is -6.29 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Japan Tissue Engineering Co., Ltd. is -93.32, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Japan Tissue Engineering Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Japan Tissue Engineering Co., Ltd. like P/E which is -93.26, P/B which is 4.09, and PEG which is 1.41. Compare them with sector averages to evaluate if the stock is priced fairly.

Japan Tissue Engineering Co., Ltd.

7774.T•JPX

Healthcare

Biotechnology

¥587.00

¥-1.00(-0.17%)

Japan Tissue Engineering Co., Ltd. (7774.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-6.29

P/E Ratio

-93.32

ROE

-0.04%

Net Margin

-0.10%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$23.84B

Shares OutstandingTotal number of shares issued

$40.61M

Book Value/ShareNet worth per share

$143.43

Revenue/ShareAnnual revenue per share

$60.48

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-6.29

Net MarginNet income as percentage of revenue

-10.41%

Operating MarginOperating income as percentage of revenue

-7.44%

ROEReturn on shareholders' equity

-4.39%

ROAReturn on total assets

-3.92%

ROCEReturn on capital employed

-3.11%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$95.67

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 7774.TFinancial Ratios Analysis details for 7774.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 7774.TSector Benchmarking details for 7774.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Japan Tissue Engineering Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Japan Tissue Engineering Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Japan Tissue Engineering Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Japan Tissue Engineering Co., Ltd.

For Japan Tissue Engineering Co., Ltd., essential financial indicators include EPS -6.29, PE -93.32, and ROE -0.04. These key ratios reveal insights into Japan Tissue Engineering Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Japan Tissue Engineering Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Japan Tissue Engineering Co., Ltd.

Metrics like Net Margin -10.41% and ROA -3.92% shed light on how well Japan Tissue Engineering Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Japan Tissue Engineering Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Japan Tissue Engineering Co., Ltd.

Using ratios such as P/B Ratio 4.09 and PEG Ratio 1.41, investors can assess whether Japan Tissue Engineering Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Japan Tissue Engineering Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Japan Tissue Engineering Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Japan Tissue Engineering Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Japan Tissue Engineering Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Japan Tissue Engineering Co., Ltd.

Investing in Japan Tissue Engineering Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Japan Tissue Engineering Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;